Completed PHASE4 INTERVENTIONAL 2-arm NCT02254252

Effects of Nicorandil on Angina Symptoms in Patients With Coronary Slow Flow

Nicorandil Versus Nitroglycerin for Symptomatic Relief of Angina in Patients With Slow Coronary Flow Phenomenon Visited in Imam Reza Hospital, Mashhad, Iran

Sponsor: Mashhad University of Medical Sciences

Conditions Normal, or Near Normal Coronary Angiography Slow Coronary Flow Stable Angina

Interventions Nicorandil Nitroglycerin

Updated 7 times since 2017 Last updated: Mar 28, 2015 Started: Mar 31, 2012 Primary completion: Mar 31, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Normal, or Near Normal Coronary Angiography and Slow Coronary Flow, this trial is completed. The trial is conducted by Mashhad University of Medical Sciences and has accumulated 7 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mashhad University of Medical Sciences

Data source: Mashhad University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.